Medtronic Return on Investment 2012-2026 | MDT
Current and historical return on investment (ROI) values for Medtronic (MDT) over the last 10 years.
| Medtronic ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-01-31 | $6.03B | $56.19B | 10.73% |
| 2025-10-31 | $6.21B | $74.59B | 8.33% |
| 2025-07-31 | $6.12B | $73.78B | 8.29% |
| 2025-04-30 | $5.96B | $73.82B | 8.07% |
| 2025-01-31 | $5.57B | $73.94B | 7.54% |
| 2024-10-31 | $5.41B | $74.57B | 7.25% |
| 2024-07-31 | $5.16B | $75.09B | 6.87% |
| 2024-04-30 | $5.15B | $75.43B | 6.82% |
| 2024-01-31 | $5.66B | $75.84B | 7.46% |
| 2023-10-31 | $5.57B | $75.26B | 7.40% |
| 2023-07-31 | $5.63B | $74.62B | 7.54% |
| 2023-04-30 | $5.49B | $73.24B | 7.49% |
| 2023-01-31 | $5.59B | $72.51B | 7.71% |
| 2022-10-31 | $5.86B | $73.31B | 7.99% |
| 2022-07-31 | $6.02B | $74.55B | 8.07% |
| 2022-04-30 | $5.75B | $76.37B | 7.53% |
| 2022-01-31 | $5.69B | $77.59B | 7.33% |
| 2021-10-31 | $5.30B | $77.70B | 6.83% |
| 2021-07-31 | $4.67B | $77.33B | 6.04% |
| 2021-04-30 | $4.48B | $76.25B | 5.88% |
| 2021-01-31 | $3.20B | $74.98B | 4.26% |
| 2020-10-31 | $3.56B | $74.79B | 4.76% |
| 2020-07-31 | $3.98B | $74.59B | 5.33% |
| 2020-04-30 | $4.79B | $75.09B | 6.38% |
| 2020-01-31 | $6.42B | $75.54B | 8.50% |
| 2019-10-31 | $6.32B | $74.77B | 8.46% |
| 2019-07-31 | $6.52B | $74.25B | 8.78% |
| 2019-04-30 | $6.27B | $73.93B | 8.48% |
| 2019-01-31 | $6.25B | $73.88B | 8.46% |
| 2018-10-31 | $6.14B | $74.54B | 8.24% |
| 2018-07-31 | $6.49B | $75.58B | 8.59% |
| 2018-04-30 | $6.64B | $76.26B | 8.71% |
| 2018-01-31 | $6.40B | $76.69B | 8.34% |
| 2017-10-31 | $6.11B | $76.48B | 7.98% |
| 2017-07-31 | $5.60B | $76.93B | 7.28% |
| 2017-04-30 | $5.38B | $78.00B | 6.90% |
| 2017-01-31 | $5.27B | $79.48B | 6.64% |
| 2016-10-31 | $5.48B | $81.75B | 6.71% |
| 2016-07-31 | $5.40B | $83.41B | 6.47% |
| 2016-04-30 | $5.36B | $84.79B | 6.32% |
| 2016-01-31 | $3.95B | $85.99B | 4.59% |
| 2015-10-31 | $3.87B | $76.57B | 5.05% |
| 2015-07-31 | $3.76B | $62.37B | 6.03% |
| 2015-04-30 | $3.77B | $48.13B | 7.82% |
| 2015-01-31 | $3.91B | $33.82B | 11.57% |
| 2014-10-31 | $3.66B | $29.36B | 12.47% |
| 2014-07-31 | $3.68B | $29.17B | 12.60% |
| 2014-04-30 | $3.81B | $28.81B | 13.23% |
| 2014-01-31 | $4.70B | $28.48B | 16.50% |
| 2013-10-31 | $4.89B | $27.53B | 17.77% |
| 2013-07-31 | $4.87B | $26.56B | 18.34% |
| 2013-04-30 | $4.76B | $25.68B | 18.51% |
| 2013-01-31 | $4.78B | $24.70B | 19.35% |
| 2012-10-31 | $4.71B | $24.77B | 19.03% |
| 2012-07-31 | $4.75B | $24.87B | 19.09% |
| 2012-04-30 | $4.75B | $24.85B | 19.11% |
| 2012-01-31 | $4.52B | $24.75B | 18.24% |
| 2011-10-31 | $4.51B | $24.01B | 18.78% |
| 2011-07-31 | $4.38B | $23.26B | 18.82% |
| 2011-04-30 | $4.30B | $22.54B | 19.06% |
| 2011-01-31 | $4.37B | $21.92B | 19.94% |
| 2010-10-31 | $4.49B | $21.39B | 21.00% |
| 2010-07-31 | $4.63B | $20.89B | 22.15% |
| 2010-04-30 | $4.71B | $20.33B | 23.19% |
| 2010-01-31 | $4.32B | $19.80B | 21.81% |
| 2009-10-31 | $4.03B | $19.36B | 20.82% |
| 2009-07-31 | $3.89B | $18.91B | 20.56% |
| 2009-04-30 | $3.83B | $18.48B | 20.74% |
| 2009-01-31 | $4.37B | $17.95B | 24.34% |
| 2008-10-31 | $4.08B | $17.46B | 23.35% |
| 2008-07-31 | $3.88B | $17.17B | 22.58% |
| 2008-04-30 | $3.66B | $16.91B | 21.62% |
| 2008-01-31 | $3.42B | $16.72B | 20.48% |
| 2007-10-31 | $3.68B | $16.70B | 22.01% |
| 2007-07-31 | $3.72B | $16.42B | 22.66% |
| 2007-04-30 | $3.71B | $16.09B | 23.07% |
| 2007-01-31 | $3.78B | $15.67B | 24.12% |
| 2006-10-31 | $3.73B | $14.71B | 25.34% |
| 2006-07-31 | $3.70B | $13.78B | 26.82% |
| 2006-04-30 | $3.34B | $13.08B | 25.55% |
| 2006-01-31 | $3.28B | $12.46B | 26.29% |
| 2005-10-31 | $3.26B | $12.33B | 26.41% |
| 2005-07-31 | $3.17B | $12.27B | 25.87% |
| 2005-04-30 | $3.44B | $11.50B | 29.95% |
| 2005-01-31 | $3.41B | $10.66B | 32.00% |
| 2004-10-31 | $3.29B | $9.78B | 33.62% |
| 2004-07-31 | $3.23B | $8.88B | 36.35% |
| 2004-04-30 | $3.14B | $9.06B | 34.67% |
| 2004-01-31 | $2.97B | $9.26B | 32.11% |
| 2003-10-31 | $2.89B | $9.48B | 30.49% |
| 2003-07-31 | $2.66B | $9.69B | 27.48% |
| 2003-04-30 | $2.54B | $8.84B | 28.73% |
| 2003-01-31 | $2.39B | $7.98B | 29.98% |
| 2002-10-31 | $2.22B | $7.13B | 31.10% |
| 2002-07-31 | $1.96B | $6.30B | 31.07% |
| 2002-04-30 | $1.86B | $6.06B | 30.61% |
| 2002-01-31 | $1.78B | $5.83B | 30.57% |
| 2001-10-31 | $1.74B | $5.63B | 30.96% |
| 2001-07-31 | $1.92B | $5.42B | 35.51% |
| 2001-04-30 | $1.88B | $5.16B | 36.43% |
| 2001-01-31 | $1.74B | $4.91B | 35.47% |
| 2000-10-31 | $1.69B | $4.60B | 36.64% |
| 2000-07-31 | $1.62B | $4.33B | 37.46% |
| 2000-04-30 | $1.55B | $4.10B | 37.79% |
| 2000-01-31 | $1.14B | $3.88B | 29.44% |
| 1999-10-31 | $1.07B | $3.75B | 28.59% |
| 1999-07-31 | $1.18B | $3.51B | 33.64% |
| 1999-04-30 | $1.37B | $3.07B | 44.72% |
| 1999-01-31 | $1.61B | $2.67B | 60.35% |
| 1998-10-31 | $1.49B | $2.25B | 66.28% |
| 1998-07-31 | $1.22B | $2.00B | 60.79% |
| 1998-04-30 | $0.88B | $1.95B | 45.22% |
| 1998-01-31 | $0.86B | $1.87B | 45.80% |
| 1997-10-31 | $0.84B | $1.91B | 44.20% |
| 1997-07-31 | $0.82B | $1.93B | 42.38% |
| 1997-04-30 | $0.78B | $1.95B | 40.26% |
| 1997-01-31 | $0.75B | $1.96B | 38.24% |
| 1996-10-31 | $0.72B | $1.45B | 50.08% |
| 1996-07-31 | $0.69B | $1.35B | 51.17% |
| 1996-04-30 | $0.65B | $0.86B | 75.35% |
| 1996-01-31 | $0.60B | $0.75B | 79.47% |
| 1995-10-31 | $0.54B | $0.75B | 71.87% |
| 1995-07-31 | $0.49B | $0.65B | 75.21% |
| 1995-04-30 | $0.44B | $0.94B | 46.30% |
| 1995-01-31 | $0.41B | $0.87B | 46.74% |
| 1994-10-31 | $0.39B | $1.13B | 34.17% |
| 1994-07-31 | $0.37B | $1.06B | 34.46% |
| 1994-04-30 | $0.33B | $0.77B | 43.37% |
| 1994-01-31 | $0.32B | $0.71B | 44.65% |
| 1993-10-31 | $0.31B | $0.46B | 66.92% |
| 1993-07-31 | $0.29B | $0.21B | 136.15% |
| 1993-04-30 | $0.30B | $0.21B | 138.50% |
| 1993-01-31 | $0.28B | $0.20B | 140.62% |
| 1992-10-31 | $0.27B | $0.41B | 66.83% |
| 1992-07-31 | $0.26B | $0.60B | 43.36% |
| 1992-04-30 | $0.25B | $0.79B | 31.24% |
| 1992-01-31 | $0.24B | $0.76B | 31.09% |
| 1991-10-31 | $0.23B | $0.73B | 31.28% |
| 1991-07-31 | $0.22B | $0.53B | 41.07% |
| 1991-04-30 | $0.21B | $0.49B | 41.91% |
| 1991-01-31 | $0.20B | $0.46B | 43.29% |
| 1990-10-31 | $0.19B | $0.43B | 44.16% |
| 1990-07-31 | $0.18B | $0.57B | 31.84% |
| 1990-04-30 | $0.18B | $0.56B | 31.53% |
| 1990-01-31 | $0.17B | $0.53B | 31.02% |
| 1989-10-31 | $0.16B | $0.51B | 31.32% |
| 1989-07-31 | $0.16B | $0.50B | 31.73% |
| 1989-04-30 | $0.14B | $0.48B | 28.50% |
| 1989-01-31 | $0.12B | $0.46B | 27.06% |
| 1988-10-31 | $0.12B | $0.44B | 27.41% |
| 1988-07-31 | $0.12B | $0.42B | 27.36% |
| 1988-04-30 | $0.13B | $0.42B | 31.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $111.968B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |